Drug Trial Radar · NCT00226096
Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
Last checked: Nov 19, 2026Latest source record: Jun 26, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
404
Actual
Start
Nov 2005
Primary completion
Sep 2007
Study completion Sep 2007
Sponsor
- Lead sponsor
- The George InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Health and Medical Research Council, Australia
- First posted
- Sep 26, 2005
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to determine whether lowering high blood pressure levels after the start of a stroke caused by bleeding in the brain (intracerebral haemorrhage) will reduce the chances of a person dying or surviving with a long term disability. The study will be undertaken in two phases: a vanguard phase in 400 patients, to plan for a main phase in 2000 patients.
Conditions
- CVA (Cerebrovascular Accident)
- Cerebral Hemorrhage
- Intracranial Hemorrhages
Interventions
Labetalol HydrochlorideDrug
Metoprolol tartrateDrug
Hydralazine HydrochlorideDrug
Glycerol TrinitrateDrug
Phentolamine mesylateDrug
NicardipineDrug
UrapidilDrug
EsmololDrug
ClonidineDrug
EnalaprilatDrug
NitroprussideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Combination death and dependency, according to a 3-6 scores on the modified Rankin Score.Time frame: 3 months
Locations
20 sites in 3 countries. Site status is shown where the registry gives one.
Concord Hospital
Concord, New South Wales, Australia
Gosford Hospital
Gosford, New South Wales, Australia
St George Hospital
Kogarah, New South Wales, Australia
John Hunter Hospital
Newcastle, New South Wales, Australia
St Vincent's Hospital
Sydney, New South Wales, Australia
Royal Prince Alfred Hospital
Sydney, New South Wales, Australia
Westmead Hospital
Westmead, New South Wales, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Royal Melbourne Hospital
Melbourne, Victoria, Australia
St Vincent's Hospital
Melbourne, Victoria, Australia
Box Hill Hospital
Melbourne, Victoria, Australia
Alfred Hospital
Melbourne, Victoria, Australia
Austin Health
Melbourne, Victoria, Australia
Monash Medical Centre
Melbourne, Victoria, Australia
Sir Charles Gairdner Hospital
Perth, Western Australia, Australia
Regional Coordinating Centre: Peking University First Hospital
Beijing, China
Hospitals in China, c/o The George Institute China
Beijing, China
Regional Coordinating Centre: Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Second Medical University
Shanghai, China
North Shore Hospital
Auckland, New Zealand
Christchurch Hospital
Christchurch, New Zealand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.